MHRA - Innovative Licensing and Access Pathway (ILAP)

30th January 2025

MHRA - Innovative Licensing and Access Pathway (ILAP)

Full details have been published today of the refreshed UK-wide Innovative Licensing and Access Pathway (ILAP), that will offer a clearer, more streamlined and integrated process for developers to help get transformative new medicines to patients in the National Health Service (NHS) in the shortest time possible. 

Read News Story

Read Guidance

Back to News Archive